Last updated: 11/07/2018 14:41:50
Effect of Acarbose on the Pharmacokinetics of BRL 49653C in Healthy Adult Volunteers
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Effect of Acarbose on the Pharmacokinetics of BRL 49653C in Healthy Adult Volunteers
Trial description: Effect of Acarbose on the Pharmacokinetics of BRL 49653C in Healthy Adult Volunteers
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Inglis AM, Miller AK, Thompson KA, Jorkasky DK, Freed MI. Coadministration of rosiglitazone and acarbose: lack of a clinically relevant pharmacokinetic drug interaction. Diabetes 1998; 47 (Suppl 1): A353. Abs 1366 presented at ADA 1998.
Miller AK, Inglis AM, Culkin KT, Jorkasky DK, Freed MI. The effect of acarbose on the pharmacokinetics of rosiglitazone. Eur J Clin Pharmacol 2001; 57: 105-109. Eur J Clin Pharmacol DOI 10. 1007/s002280100275. HTML article published online April 2001.
The effect of acarbose on the pharmacokinetics of rosiglitazone. Miller, A. K., Inglis, A. M., Culkin, K. T., Jorkasky, D. K., and Freed, M. I. Eur J Clin Pharmacol 2001; 57(2):105-9
Medical condition
Diabetes Mellitus, Type 2
Product
rosiglitazone
Collaborators
Not applicable
Study date(s)
July 1997 to August 1997
Type
Not applicable
Phase
1
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1997-12-08
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website